Myomo (MYO) Share-based Compensation (2016 - 2025)
Myomo's (MYO) quarterly Share-based Compensation came in at $583991.0 in Q3 2025, up 18.75% on a YoY basis from $491770.0 in Q3 2024, and down 8.32% quarter-over-quarter from $636974.0 in Q2 2025.
Powered by 
Analysis
Myomo (MYO) Share-based Compensation (2016 - 2025) Analysis & Trends
Myomo (MYO) has reported Share-based Compensation for 10 consecutive years, with $583991.0 the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Share-based Compensation rose 18.75% year-over-year to $583991.0; the trailing twelve-month figure through Sep 2025 stood at $8.2 million (up 1565.02% YoY), and the FY2024 full-year result was $7.5 million, up 571.58% from the prior year.
- Share-based Compensation retreated to $583991.0 in Q3 2025 per MYO's latest filing, from $636974.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $6.9 million in Q4 2024 and bottomed at $171027.0 in Q1 2023.
- Historically, Share-based Compensation has averaged $826134.1 across 5 years, with a median of $345223.0 in 2022.
- The sharpest annual moves came in 2023 and 2024: Share-based Compensation sank 54.32% in 2023, then soared 1977.17% in 2024.
- Over 5 years, Share-based Compensation stood at $265362.0 in 2021, then climbed by 3.02% to $273368.0 in 2022, then gained by 22.21% to $334089.0 in 2023, then jumped by 1977.17% to $6.9 million in 2024, then sank by 91.58% to $583991.0 in 2025.
- According to Business Quant data, Share-based Compensation over the past three periods registered $583991.0, $636974.0, and $1.8 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 67.10 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 125.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 7.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 61.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 42.20 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 42.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 39.00 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Myomo | 54.96 Mn | 35.99 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 583,991.00 |
| Jun 30, 2025 | 636,974.00 |
| Mar 31, 2025 | 1.82 Mn |
| Dec 31, 2024 | 6.94 Mn |
| Sep 30, 2024 | 491,770.00 |
| Jun 30, 2024 | 493,970.00 |
| Mar 31, 2024 | 1.12 Mn |
| Dec 31, 2023 | 334,089.00 |
| Sep 30, 2023 | 330,394.00 |
| Jun 30, 2023 | 280,061.00 |
| Mar 31, 2023 | 171,027.00 |
| Dec 31, 2022 | 273,368.00 |
| Sep 30, 2022 | 305,633.00 |
| Jun 30, 2022 | 345,223.00 |
| Mar 31, 2022 | 374,432.00 |
| Dec 31, 2021 | 265,362.00 |
| Sep 30, 2021 | 301,763.00 |
| Jun 30, 2021 | 363,312.00 |
| Mar 31, 2021 | 266,031.00 |
| Dec 31, 2020 | 90,832.00 |